Navigation Links
Blau, Brown & Leonard, LLC Settlements Near Two Million Dollars on Behalf of Women who Endured DVT's, PE's and Strokes from Yaz, Yasmin and Ocella
Date:12/13/2012

New York, NY (PRWEB) December 13, 2012

Sales of Yaz and Yasmin continue to surge according to Bayer's thrid quarter shareholder release. http://www.stockholders-newsletter-q3-2012.bayer.com/en/bayer-healthcare.aspx

Blau, Brown & Leonard, LLC settlements continue to grow and are nearing $2,000,000 on behalf of women who sustained blood clots from YAZ, YASMIN, OCELLA or BEYAZ . Their cases may be followed on the New Jersey Mass Tort Docket at http://www.judiciary.state.nj.us/mass-tort/yaz/index.htm also known as IN RE YAZ, YASMIN, OCELLA, Case No. 287, Bergen County, Law Division.

Blau, Brown & Leonard, LLC, pioneers in birth control litigation, have a 24/7 hotline at (800) YAZ-0287 to field calls about the settlement process. Individuals who have questions of whether they are eligible to participate in the settlement funds can call toll free 24/7 to (800) 929-0287 to receive a free, confidential consultation directly with an attorney. In July 2012, Bloomberg News reported that Bayer had reserved another $610 million to settle more cases relating to blood clots. Blau, Brown & Leonard, LLC have settled many cases at an average exceeding $200,000 per case.

Bayer, the makers of YAZ, YASMIN, OCELLA and BEYAZ are in the settlement phase of this litigation for cases of women who sustained blood clot injuries from their birth control.

In April of this year, the FDA issues a Drug Safety Advisory entitled, "information about the risk of blood clots in women taking birth control pills containing drospirenone" - the active ingredient in Yaz, Yasmin, and Ocella. According to the FDA, women who take this type of birth control have an increased risk of blood clots. These blood clot injuries include DVT, also known as Deep Vein Thrombosis, P.E., short for Pulmonary Embolism, Stroke, Heart Attack or Death.

Each state has different laws governing when an action must be commenced and medical records need to be gathered in a timely manner before they are no longer obtainable. The cases must be put into suit promptly to protect the rights of the woman or else the right to monetary compensation may be barred by the Statute of Limitations. Educated lawyers who have been part of the Yaz litigation from start to finish are standing by at (800) YAZ-0287 to field questions about the settlement, how to participate, and whether an individual may be entitled to compensation.

DVT's, PE's, Stroke, Heart Attack are Part of the Settlement

The signature injury that Bayer is including in the settlement at this point are blood clot related injuries. Blood clots are the thickening of the blood within the body causing restricted blood flow in an area and a potentially life threatening situation. All hormonal birth control can cause blood clots, but according to the FDA, the fourth generation hormone known as drospirenone in Yaz, Yasmin, Beyaz and Ocella, have been shown to have an elevated risk of clotting events. Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), strokes, and heart attacks may all be linked to blood clots from Yaz, Yasmin, Beyaz and Ocella. The Yaz lawsuit is consolidated into an MDL, which is known as a multi-district litigation, docket number MDL 2100 in Illinois (http://www.ilsd.uscourts.gov/mdl/mdl2100.aspx) and as a mass tort in New Jersey State Courts.

About Blau, Brown & Leonard, LLC

Blau, Brown & Leonard, LLC is a law firm representing women nationwide who have been injured by Yaz, Yasmin, Ocella or BeYaz. The firm has a toll free number dedicated to educating women about their rights in this litigation at (800) YAZ-0287. Blau, Brown & Leonard, LLC is a formidable team of trial attorneys who have experience working mass torts and many million dollar settlements and judgments on behalf of their clients. Managing Partner Jason T. Brown was a former Special Agent and Legal Adviser to the Federal Bureau of Investigation (FBI) and is lead counsel in class actions all over the country. Often times, Mr. Brown will field calls and questions directly. There is no fee unless the firm is successful with the case.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10192800.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lifespan/Tufts/Brown Center for AIDS Research renewed with $8.5 million NIH grant
2. Beige Fat Joins Brown Fat as Potential Weight-Loss Target
3. Research shows efficacy of treatment model developed at Women & Infants
4. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
5. Vendors in Nevada, Michigan, & Illinois to be Featured on the PartyPOP.com Online Network
6. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
7. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
8. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
9. Play & Park Structures Included in New Play for All Abilities Playground
10. Gum Disease, HPV May Play Role in Head & Neck Cancers
11. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR ... Medical has introduced an innovative workstation designed to reduce nursing fatigue while enhancing ... Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the limitations ...
(Date:2/17/2017)... Church, VA (PRWEB) , ... ... ... Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. 22, ... , What are the critical reimbursement questions manufacturers should be asking before ...
(Date:2/17/2017)... Texas (PRWEB) , ... February 17, 2017 , ... ... 8.0 at the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors ... version of the most widely used electronic patient signatures solution in healthcare ...
(Date:2/17/2017)... ... February 17, 2017 , ... PrideStaff, a national ... was named to Staffing Industry Analysts' 2017 "Staffing 100 North America" list. ... made notable contributions to the staffing industry over the last twelve months. Industry ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... planning assistance to families and business owners in and around the Hampton Roads ... to help prevent all forms of domestic violence. , There are multiple categories ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... --  Risperdal lawsuits involving gynecomastia (male breast growth) ... the atypical antipsychotic medication continue to move forward in ... Pleas, where the state,s Risperdal docket has been centralized ... posted on the Court,s website , the litigation ... 2017 at 11:00 a.m. (In Re: Risperdal Litigation, Case ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017 /PRNewswire/ ... announced today the partnership of their 3D body ... in healthcare IT.  The new integration will be ... on an interactive model of the human body. ... data saves clinicians time, while also increasing the ...
(Date:2/16/2017)... , Feb. 16, 2017 Research and ... for Emerging Medical Device Technologies" report to their offering. ... ... open procedures, general instruments, non-drug coated implantables, large endoscopes, needle ... in use over the last two to three decades for ...
Breaking Medicine Technology: